Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(25)
DRUG(7)
PROCEDURE(2)
RADIATION(1)
Cyclophosphamide
4 trials
phase_2
sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university
Tacrolimus
4 trials
phase_2
sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university
Donor Lymphocyte Infusion (DLI)
4 trials
phase_2
sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university
Mycophenolate mofetil
3 trials
phase_2
sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university
Total Body Irradiation (TBI)
3 trials
phase_1_2phase_2
sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university
Mycophenolate Mofetil (MMF)
2 trials
phase_2
sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university
Hematopoietic stem cell transplantation (HSCT)
2 trials
phase_1_2phase_2
sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university
Allogeneic hematopoietic stem cell transplantation
2 trials
not_applicablephase_2
sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university

+11 more interventions

19 unique interventions5 categories

Analytics

Trial Phases

Phase 11
Phase 26

Trial Status

Completed3
Terminated3
Other1

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT01982682Phase 2Completed
Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
Hematopoietic/Lymphoid Cancer
PrincipalinvestigatorStart date: 2013-11-04
NCT01871441Phase 2Terminated
Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Malignant Neoplasm
PrincipalinvestigatorStart date: 2013-05-17
NCT01341301Phase 2Completed
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Hematologic Malignancy
Principalinvestigator
NCT01350245Phase 2Completed
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+7 more
Principalinvestigator
NCT01350258Phase 1/2Terminated
Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps
Acute LeukemiaChronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI TherapyHematologic Malignancies+4 more
Principalinvestigator
NCT01532635Phase 2Terminated
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaALL+9 more
Principalinvestigator
NCT01660347Not ApplicableWithdrawn
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
AnemiaHematopoietic/Lymphoid CancerLymphopenia+2 more
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Neal Flomenberg, MD

Thomas Jefferson University

Very Similar
7 trials

Shared therapeutic areas:

Hematologic NeoplasmsHodgkin DiseaseLeukemia, Lymphocytic, Chronic, B-Cell+17 more

Worked with same sponsors:

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Collaborated on 4 trials
Similarity Score216%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+5 more
Similarity Score9%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsCancer+3 more
Similarity Score7%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesHematologic Neoplasms+3 more
Similarity Score7%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+3 more
Similarity Score7%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLeukemiaHodgkin Disease+1 more
Similarity Score5%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphomaHematologic Neoplasms
Similarity Score3%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

CancerLeukemia
Similarity Score2%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

CancerHematopoietic/Lymphoid Cancer
Similarity Score2%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT01982682Phase 2PrincipalInvestigator

Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor

Hematopoietic/Lymphoid Cancer
Completed
NCT01871441Phase 2PrincipalInvestigator

Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Malignant Neoplasm
Terminated
NCT01341301Phase 2PrincipalInvestigator

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Hematologic Malignancy
Completed
NCT01350245Phase 2PrincipalInvestigator

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+7 more
Completed
NCT01350258Phase 1/2PrincipalInvestigator

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Acute LeukemiaChronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI TherapyHematologic Malignancies+4 more
Terminated
NCT01532635Phase 2PrincipalInvestigator

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaALL+9 more
Terminated
NCT01660347Not ApplicablePrincipalInvestigator

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

AnemiaHematopoietic/Lymphoid CancerLymphopenia+2 more
Withdrawn

All 7 trials loaded